Healthcare -
Biotechnology - NASDAQ - US
$ 2.005
-3.14 %
$ 143 M
Market Cap
-0.8
P/E
ZNTL - STOCK-BASED COMPENSATION
Stock-based Compensation ZNTL - Zentalis Pharmaceuticals, Inc.
54.8 M
LAST VALUE
23.86%
2 YEAR CAGR
181.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR